Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
Tissue Plasminogen Activator–Induced Reperfusion Injury After Stroke Revisited
IJMS, Free Full-Text
SGEM Xtra: The NNT is Mellow Yellow for tPA in Acute Ischemic Stroke - The Skeptics Guide to Emergency Medicine
Frontiers Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature
Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial - The Lancet Neurology
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin - ScienceDirect
Reperfusion therapy in acute ischemic stroke: dawn of a new era?, BMC Neurology
Thrombolysis in Stroke Mimics Is Not Harmless - ACEP Now
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis - The Lancet
%20market-figure-1.png)
Acute Ischemic Stroke (AIS) Market Size and Forecast to 2030
Approach to reperfusion therapy for acute ischemic stroke - UpToDate
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways - ScienceDirect
IJERPH, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
